799-4975019-3/11/1

Takeda Pharmaceutical Company Limited — FEI 3002808311

Refusal Details

Date
October 19, 2021
Country
Japan
Product Category
Drugs and Biologics
Product Code
62IDA99 ANTI-NEOPLASTIC N.E.C.
Charges
118,75